This video explores the current treatment landscape for lower-risk MDS patients, including the various agents and sequencing strategies employed to best optimize outcomes.
Valeria Santini, MD
Advertisement
Articles by Valeria Santini, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
I-DXd Earns FDA Priority Review in Extensive-Stage Small Cell Lung Cancer
2
FDA Grants Fast Track Designation to Daretabart for High-Risk Neuroblastoma
3
Daraxonrasib Shows "Unprecedented" Survival in Pretreated Pancreatic Cancer
4
REGN5668 Combo Yields Preliminary Activity in Recurrent Ovarian/Endometrial Cancer
5